Recommended Initial Insulin Regimen for Type 2 Diabetes
For patients with type 2 diabetes inadequately controlled on oral medications, initiate basal insulin at 10 units once daily (or 0.1-0.2 units/kg body weight) administered at the same time each day, continuing metformin and potentially one additional non-insulin agent. 1, 2, 3
Starting Dose Algorithm
Standard initiation (HbA1c <9%):
- Start with 10 units once daily OR 0.1-0.2 units/kg body weight 1, 2
- Administer at bedtime or with evening meal 1, 4
- Continue metformin unless contraindicated 1, 2
Severe hyperglycemia (HbA1c ≥9% or glucose ≥300-350 mg/dL):
- Consider higher starting doses of 0.3-0.5 units/kg/day as total daily dose 2, 5
- For HbA1c ≥10-12% with symptomatic/catabolic features, initiate basal-bolus regimen immediately rather than basal insulin alone 2
- Split dose: 50% as basal insulin, 50% as rapid-acting prandial insulin divided among meals 2, 5
Dose Titration Protocol
Increase basal insulin systematically based on fasting glucose: 1, 2
- If fasting glucose ≥180 mg/dL: increase by 4 units every 3 days
- If fasting glucose 140-179 mg/dL: increase by 2 units every 3 days
- Target fasting glucose: 80-130 mg/dL 2
Alternative titration approach: 1
- Increase by 10-15% of current dose once or twice weekly until target reached
- Empower patients with self-titration algorithms based on self-monitoring 1, 3
Critical Threshold: When to Stop Escalating Basal Insulin
When basal insulin exceeds 0.5 units/kg/day and approaches 1.0 units/kg/day, add prandial insulin rather than continuing to escalate basal insulin alone. 2 This prevents "overbasalization"—a dangerous pattern where excessive basal insulin masks inadequate mealtime coverage. 2
Clinical signals of overbasalization include: 2
- Basal insulin dose >0.5 units/kg/day
- Bedtime-to-morning glucose differential ≥50 mg/dL
- Hypoglycemia episodes
- High glucose variability
Adding Prandial Insulin (When Needed)
Indications for adding prandial insulin: 2
- Basal insulin optimized (fasting glucose 80-130 mg/dL) but HbA1c remains above target after 3-6 months
- Basal insulin dose approaches 0.5-1.0 units/kg/day without achieving HbA1c goal
- Significant postprandial glucose excursions persist
Starting prandial insulin dose: 1, 2
- 4 units of rapid-acting insulin before the largest meal, OR
- 10% of current basal insulin dose per meal (if HbA1c <8%)
- Consider decreasing basal insulin by the same amount as starting mealtime dose 1
Insulin Product Selection
Long-acting basal insulin options: 1, 3
- Insulin glargine (Lantus, Toujeo) or detemir (Levemir) are preferred due to reduced hypoglycemia risk compared to NPH 3, 6
- NPH insulin may be more affordable for cost-sensitive patients, though it causes more hypoglycemia 1
Rapid-acting insulin analogues (for prandial coverage): 1
- Preferred over regular insulin due to quick onset of action
- Administered 0-15 minutes before meals 6
Foundation Therapy Considerations
Continue metformin when initiating insulin: 1, 2, 3
- Metformin combined with insulin reduces weight gain, lowers insulin requirements, and decreases hypoglycemia risk 6
- Do not abruptly discontinue oral medications due to rebound hyperglycemia risk 6
Alternative to intensifying insulin: 2
- Consider adding GLP-1 receptor agonist to basal insulin regimen to improve HbA1c while minimizing weight gain and hypoglycemia 2
Essential Patient Education
Before initiating insulin therapy, provide comprehensive education on: 1, 3
- Blood glucose self-monitoring techniques
- Hypoglycemia recognition and treatment
- Proper insulin injection technique and site rotation 2, 6
- Nutrition management
- "Sick day" management rules 2
- Insulin storage and handling 2
Common Pitfalls to Avoid
Do not delay insulin initiation in patients failing to achieve glycemic goals on oral medications—diabetes is progressive and many patients eventually require insulin 1, 2
Do not use insulin as a threat or describe it as punishment; regularly explain the progressive nature of type 2 diabetes objectively 3
Do not continue escalating basal insulin beyond 0.5-1.0 units/kg/day without addressing postprandial hyperglycemia—this leads to suboptimal control and increased hypoglycemia risk 2
Do not rely solely on sliding scale insulin for prolonged periods in hospitalized patients—scheduled basal-bolus regimens provide superior glycemic control 5, 6
Monitoring Requirements
During titration phase: 2
- Daily fasting blood glucose monitoring is essential
- Assess insulin dose adequacy at every clinical visit
- Check HbA1c every 3 months during intensive titration
Hypoglycemia management: 2
- If hypoglycemia occurs without clear cause, reduce dose by 10-20% immediately
- If >2 fasting glucose values per week are <80 mg/dL, decrease basal insulin by 2 units 2
Special Populations
Hospitalized patients (insulin-naive): 5
- Start with 0.3-0.5 units/kg/day total daily dose
- Give 50% as basal insulin, 50% as rapid-acting insulin before meals
- Use lower doses (0.3 units/kg/day) for high-risk patients: age >65 years, renal failure, or poor oral intake 5
Patients on high-dose home insulin (≥0.6 units/kg/day): 2
- Reduce total daily dose by 20% upon hospitalization to prevent hypoglycemia